MEI Pharma Inc (MEIP) — Capital Reinvestment Ratio

Latest as of December 2020: 0.01x

MEI Pharma Inc (MEIP) has a Capital Reinvestment Ratio of 0.01x as of December 2020, meaning it reinvests 0% of its operating cash flow ($4.05 Million) in capital expenditures ($56.00K). Check MEIP intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

$4.05 Million
USD

Capital Expenditures

$56.00K
USD

Data as of

Dec 2020
Most recent filing

MEI Pharma Inc Capital Reinvestment Ratio (2017–2020)

This chart tracks MEI Pharma Inc's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see MEIP cash flow conversion.

Annual Capital Reinvestment Ratio for MEI Pharma Inc (2017–2020)

Year-by-year Capital Reinvestment Ratio for MEI Pharma Inc from 2017 to 2020. See MEI Pharma Inc (MEIP) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2020 0.03x $34.26 Million $894.00K ▲ +78.4%
2017 0.01x $3.49 Million $51.00K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow